Cigarettes in Singapore, 2017
SynopsisSingapore is important as a major distribution center for the Asia-Pacific region, but its relatively small population, currently around 5.7 million, means it has only a small domestic cigarette market. Annual per capita consumption levels are relativelylow in regional terms, averaging 514 pieces in 2014. However, the effects of the economic difficulties, increased taxes, high non-duty paid sales, competition from RYO cigarettes, and a tightening of restrictions on tobacco consumption have depressed demand for manufactured cigarettes.
Summary
The local market is dominated by filter cigarettes, which account for virtually 100% of sales or 2.87 billion pieces in 2014. Most of the industrial activity in the Singapore cigarette market is centered on the import and re-export of cigarettes. The market has been almost entirely contested between three companies: Philip Morris Singapore (PMI), British American Tobacco Singapore (BAT) and Japan Tobacco International (JTI). The most significant development of recent years has been the emergence of the low priced sector.
Scope
Cigarettes in Singapore 2017 is an analytical report provides extensive and highly detailed current and future market trends in the Uruguay market. The report offers Market size and structure of the overall and per capita consumption based upon a unique combination of industry research, fieldwork, market sizing analysis, and our in-house expertise.
Reasons To Buy
Get a detailed understanding of consumption to align your sales and marketing efforts with the latest trends in the market. Identify the areas of growth and opportunities, which will aid effective marketing planning. The differing growth rates in regional product sales drive fundamental shifts in the market. This report provides detailed, authoritative data on these changes - prime intelligence for marketers. Understand the market dynamics and essential data to benchmark your position and to identify where to compete in the future.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.